Literature DB >> 26967022

Advantages and disadvantages of discrete-event simulation for health economic analyses.

J Jaime Caro1,2, Jörgen Möller3,4.   

Abstract

Keywords:  Simulation; discrete event; health economic analyses; health technology assessment; modeling

Mesh：

Year:  2016        PMID： 26967022     DOI： 10.1586/14737167.2016.1165608

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN： 1473-7167            Impact factor:   2.217


× No keyword cloud information.
  9 in total

Review 1.  Discrete Event Simulation-Based Resource Modelling in Health Technology Assessment.

Authors:  Syed Salleh; Praveen Thokala; Alan Brennan; Ruby Hughes; Simon Dixon
Journal:  Pharmacoeconomics       Date:  2017-10       Impact factor: 4.981

Review 2.  Decision-analytic modeling as a tool for selecting optimal therapy incorporating hematopoietic stem cell transplantation in patients with hematological malignancy.

Authors:  Shigeo Fuji; Arnon Nagler; Mohamad Mohty; Bipin Savani; Roni Shouval
Journal:  Bone Marrow Transplant       Date:  2020-01-13       Impact factor: 5.483

3.  Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling.

Authors:  Deborah A Marshall; Luiza R Grazziotin; Dean A Regier; Sarah Wordsworth; James Buchanan; Kathryn Phillips; Maarten Ijzerman
Journal:  Value Health       Date:  2020-03-26       Impact factor: 5.725

4.  Four Aspects Affecting Health Economic Decision Models and Their Validation.

Authors:  Talitha Feenstra; Isaac Corro-Ramos; Dominique Hamerlijnck; George van Voorn; Salah Ghabri
Journal:  Pharmacoeconomics       Date:  2021-12-16       Impact factor: 4.981

5.  Comparison of Decision Modeling Approaches for Health Technology and Policy Evaluation.

Authors:  John Graves; Shawn Garbett; Zilu Zhou; Jonathan S Schildcrout; Josh Peterson
Journal:  Med Decis Making       Date:  2021-03-18       Impact factor: 2.749

Review 6.  Decision modelling for economic evaluation of liver transplantation.

Authors:  Zhi Qu; Christian Krauth; Volker Eric Amelung; Alexander Kaltenborn; Jill Gwiasda; Lena Harries; Jan Beneke; Harald Schrem; Sebastian Liersch
Journal:  World J Hepatol       Date:  2018-11-27

7.  Estimating the effectiveness and cost-effectiveness of establishing additional endovascular Thrombectomy stroke Centres in England: a discrete event simulation.

Authors:  Peter McMeekin; Darren Flynn; Mike Allen; Diarmuid Coughlan; Gary A Ford; Hannah Lumley; Joyce S Balami; Martin A James; Ken Stein; David Burgess; Phil White
Journal:  BMC Health Serv Res       Date:  2019-11-08       Impact factor: 2.655

8.  Solving the Evidence Interpretability Crisis in Health Technology Assessment: A Role for Mechanistic Models?

Authors:  Eulalie Courcelles; Jean-Pierre Boissel; Jacques Massol; Ingrid Klingmann; Riad Kahoul; Marc Hommel; Emmanuel Pham; Alexander Kulesza
Journal:  Front Med Technol       Date:  2022-02-24

9.  Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States.

Authors:  Quang A Le; Joel W Hay; Russell Becker; Yamei Wang
Journal:  Ann Pharmacother       Date:  2018-08-30       Impact factor: 3.154
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.